SPC174
Glýseról fenýlbútýrat
Status:
VeittApplication date:
20.12.2016Application published:
15.1.2017Grant published:
15.3.2018
Max expiry date:
30.11.2030Medicine name:
RavictiMedicine for children:
No
Timeline
Today
20.12.2016Application
15.1.2017Publication
15.3.2018Registration
30.11.2030Expires
Marketing license
IS authorization number:
EU/1/15/1062/001-004Date:
16.12.2015
Foreign authorization number:
EU/1/15/1062Date:
27.11.2015
Owner
Name:
Immedica Pharma ABAddress:
Norrtullsgatan 15, Stockholm SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2330892